Drug Shortage Report for ALVESCO
Report ID | 119714 |
Drug Identification Number | 02285614 |
Brand name | ALVESCO |
Common or Proper name | ciclesonide |
Company Name | COVIS PHARMA GMBH |
Market Status | MARKETED |
Active Ingredient(s) | CICLESONIDE |
Strength(s) | 200MCG |
Dosage form(s) | AEROSOL, METERED DOSE |
Route of administration | INHALATION INHALATION |
Packaging size | 120 doses |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-07-08 |
Estimated end date | 2020-07-18 |
Actual end date | 2020-07-17 |
Shortage status | Resolved |
Updated date | 2020-07-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | GRAFENAUWEG 12 ZUG, ZUG SWITZERLAND 6300 |
Company contact information | Covis Pharma GmbH Grafenauweg 12 Zug, 6300 Switzerland |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-08 | English | Compare |
v2 | 2020-07-08 | French | Compare |
v3 | 2020-07-09 | English | Compare |
v4 | 2020-07-17 | English | Compare |
v5 | 2020-07-17 | French | Compare |
v6 | 2020-07-18 | English | Compare |
Showing 1 to 6 of 6